The 3-(methyleneaminoxy)methylmorpholines 2 were synthesized as analog
ues of viloxazine I, an antidepressant drug, in which the aryloxymethy
l group is substituted by a (methyleneaminoxy)methyl moiety (MAOMM). C
ompounds 2 were tested as potential antidepressant agents by using the
test of antagonism to reserpine-induced hypothermy in mice. In additi
on, their anticholinergic and antihistaminic activity on isolated prep
arations and their ability to antagonize the toxicity induced by adren
aline in mice were evaluated. ''In vivo'' and ''in vitro'' tests showe
d that some compounds of type 2 possess a pharmacological profile simi
lar to that of viloxazine 1.